Premature ovarian failure: immunological aspects and therapeutic strategies

  • Svetlana Dragojević-Dikić Gynecology and Obstetrics Clinic "Narodni front", Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Mladenko Vasiljević Gynecology and Obstetrics Clinic "Narodni front", Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Branka Nikolić Gynecology and Obstetrics Clinic "Narodni front", Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Vladimir Dragoljub Pažin Univerzitet u Beogradu, Medicinski fakultet,Ginekološko-akušerska klinika "Narodni front"
  • Lidija Tasić Gynecology and Obstetrics Clinic "Narodni front", Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Aleksandar Jurišić Gynecology and Obstetrics Clinic "Narodni front", Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Srdjan Dikić University Medical Center "Bežanijska kosa", Belgrade, Serbia
  • Živko Perišić Gynecology and Obstetrics Clinic "Narodni front", Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Abstract


za current topic nije potreban apstrakt

Author Biography

Vladimir Dragoljub Pažin, Univerzitet u Beogradu, Medicinski fakultet,Ginekološko-akušerska klinika "Narodni front"
Docent, Rukovodilac polikliničke službe u GAK "N. front"

References

Rees M, Purdie D. Premature menopause. In: Rees M, Purdie D, editors. Management of the menopause: The Handbook. London: Royal Society of Medicine Press Ltd; 2006. p. 142−9.

de Taraciuk MB, Nolting M, Fernandez G, Colela D, Onetto C , Straminsky V. Psychological assessment of patients with pre-mature ovarian failure. Gynecol Endocrin 2008; 24(1): 44–53.

Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67(4): 604−6.

Panay N, Fenton A. Premature ovarian failure: a growing con-cern. Climacteric 2008; 11(1): 1−3.

Rebar WR. Premature ovarian failure. Obstet Gynecol 2009; 113(6): 1355−63.

Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18(1): 107−34.

Conway SG, Christin-Maitre S. Premature ovarian failure. In: Fauser CJ, editor. Reproductive Medicine Molecular, Cellular and Genetic Fundamentals. New York: Parthenon Publishing; 2003. p. 587−99.

U.S. Department of Health and Human Services. National Institutes of health Autoimmune Disease Coordination Committee Report; 2002. NIH Publication 03-05. Bethesda, M.D. The Institutes; 2002.

Irvine WJ, Cahn MM, Scarth L, Kolb FO, Hartog M, Bayliss RI, et al. Immunological aspects of premature ovarian failure associated with Addison's disease. Lancet 1968; 2(7574): 883−7.

Lawrence M. Primary Ovarian Insufficiency. N Engl J Med 2009; 360(6): 606−14.

Brannstrom M, Norman RJ. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 1993; 8(10): 1762−75.

Goswami D, Conway SG. Premature ovarian failure. Hum Re-prod Update 2005; 11(4): 391−410.

Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, et al. Positional cloning of the APECED gene. Nat Genet 1997; 17(4): 393−8.

Fenichel P. Premature ovarian failure: an autoimmune disease? In: Genazzani RA, Petraglia F, Artini GP, editors. Advances in Gynecological Endocrinology. New York: Parthenon Publish-ing; 2002. p. 143−9.

Perheentupa J. APS-I/APECED: the clinical disease and ther-apy. Endocrinol Metab Clin N Am 2002; 31(2): 295−320.

Maclaren N, Chen QY, Kukreja A, Marker J, Zhang CH, Sun ZS. Autoimmune hypogonadism. J Soc Gynecol Invest 2001; 8(1): 52−4.

Schatz DA, Winter WE. Autoimmune polyglandular syndrome II: clinical syndrome and treatment. Endocrinol Metabol Clin N Am 2002; 31(2): 339−52.

Forges T, Monnier-Barbarino P, Faure CG, Bene CM. Autoimmu-nity and antigenic targets in ovarian pathology. Hum Reprod Update 2004; 10(2): 163−75.

Gleicher N, Weghofer A, Barad HD. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril 2009; 91(5): 1707−11.

Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, Bacosi ML, Bini V, Petraglia F, Falorni A. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocri-nol Metab 2008; 93(4): 1263−9.

Betterie C, Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol 1998; 138(1): 16−25.

Poppe K, Glinoer D, van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 2002; 12(11): 997−1001.

Abalovich M, Mitelberg L, Allami C, Gutierrez S, Alcaraz G, Otero P, et al. Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol Endocrinol 2007; 23(5): 279−83.

Wheatcroft NJ, Rogers CA, Metcalfe RA, Lenton EA, Cooke ID, Weetman AP. Is subclinical ovarian failure an autoimmune dis-ease? Hum Reprod 1997; 12(2): 244−9.

Luborsky J, Lianes B, Davies S, Binor Z, Radwanska E, Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 1999; 90(3): 368−74.

Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 2007; 7(1): 42−5.

Chernyshov VP, Radysh TV, Gura IV, Tatarshuk TP, Khominskaya ZB. Immune disorders in women with premature ovarian failure. Am J Reprod Immunol 2001; 46(3): 220−5.

Tung KS, Garza KM, Lou Y, Bagavant H. Autoimmune ovarian disease: mechanism of induction and prevention. J Soc Gyne-col Invest 2001; 8(1): 49−51.

Singer D, Hunter M. Premature menopause: a multidisciplinary approach. London: Whurr Publishers Ltd; 2000.

Kalu E, Panay N. Spontaneous premature ovarian failure: man-agement challenges. Gynecol Endocrinol 2008; 24(5): 273−9.

Lass A. Assessment of ovarian reserve-is there a role for ovar-ian biopsy? Hum Reprod 2001; 16(6): 1055−7.

Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ. Testing ovarian reserve to predict age at menopause. Maturitas 2009; 63(4): 280−91.

Davis SR. Premature ovarian failure. Maturitas 1996; 23(1): 1−8.

Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol 2009; 23(1): 129−40.

Birkhauser HM, Panay N, Archer FD, Barlow D, Burger H, Gam-bacciani M, et al. Updated practical recommendations for hor-mone replacement therapy in the peri- and postmenopause. Climacteric 2008; 11(2): 108−23.

Dragojević-Dikić S, Rakić S, Nikolić B, Popovac S. Hormone re-placement therapy and successful pregnancy in a patient with premature ovarian failure. Gynecol Endocrinol 2009; 25(12): 769−72.

Holroyd RC, Edwards JC. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and sys-temic lupus erythematosus. Climacteric 2009; 12(5): 378−86.

Stevenson CJ. Type and route of estrogen administration. Cli-macteric 2009; 12(1): 86−90.

Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol 2010; 26(8): 555−62.

Schwenkhagen A, Studd J. Role of testosterone in the treatment of hypoactive sexual desire disorder. Maturitas 2009; 63(2): 152−9.

Corenblum B, Rowe T. Taylor PJ. High-dose, short term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993; 59(5): 988−91.

Dragojević-Dikić S, Marisavljević D, Mitrović A, Dikić S, Jovanović T, Janković-Ražnatović S. An immunological insight into pemature ovarian failure (POF). Autoimmun Rev 2010; 9(11): 771−4.

Barbarino-Monnier P, Gobert B, Guillet-May F, Bene MC, Barbarino A, Foliguet B, Faure GC. Ovarian autoimmunity and corticotherapy in an in-vitro fertilization attempt. Hum Reprod 1995; 10(8): 2006−7.

Badawy A, Goda H, Ragab A. Induction of ovulation in idio-pathic POF: a randomized double-blind trial. Reprod Biomed Online 2007; 15(2): 215−19.

Check JH, Summers D, Nazari A, Choe J. Successful pregnancy following in vitro fertilization-embryo transfer despite immi-nent ovarian failure. Clin Exp Obstet Gynecol. 2000; 27(2): 97−9.

Published
2017/01/20
Section
Current Topic